Synergia Medical Increases Series B Funding to €12.8 Million with an Additional €3.8 Million
Synergia Medical announced the completion of an additional €3.8 million of Series B funding, allowing the preparation for FIH clinical trials planned for 2024 BELGIUM, January 18, 2023 /EINPresswire.com/ — Synergia Medical, a preclinical medical device company that has developed... Read More →
CARI Health Raises $2.3M in Seed Round to Advance Remote Medication Monitoring
Medical technology startup secures funding to begin in-patient clinical studies and prepare for regulatory pathway with FDA for first-ever wearable real-time medication monitor SAN DIEGO–(BUSINESS WIRE)–Digital health startup CARI Health has closed an oversubscribed $2.3 million seed round that will... Read More →
Pristine Surgical’s Summit arthroscope secures FDA 510(k) clearance
Summit delivers a high-definition image using a 4K single-use surgical arthroscope and the cloud-based Pristine Connect software. edical technology manufacturer Pristine Surgical has secured 510(k) clearance for its Summit 4K single-use surgical arthroscope from the US Food and Drug Administration... Read More →
AVS (formerly known as Calcium Solutions) Raises $20 Million in Series B Round to Advance Pulsatile Intravascular Lithotripsy (PIVL) Solutions
BioStar Capital leads round to accelerate clinical trials and development in peripheral and coronary solutions BOSTON–(BUSINESS WIRE)–AVS, an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™ therapy, announced today that it... Read More →
Prapela Receives FDA’s Breakthrough Device Designation to Investigate the Use of Stimulation to Treat Apnea of Prematurity
FDA Breakthrough Device Designations speed up the development and review of medical devices that can improve the lives of people with life-threatening or debilitating conditions. Every year, approximately 1.6 million newborns will experience clinically significant apnea. Prapela’s stimulation pad could... Read More →
Zimmer Biomet to Acquire Embody, Inc.
Deal Strengthens Zimmer Biomet’s Growing Sports Medicine Portfolio and Supports Continued Company Transformation WARSAW, Ind., Jan. 5, 2023 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it has reached a... Read More →
Mayo Clinic takes a stake in PillBot developer Endiatx
Mayo Clinic and Endiatx have signed a know-how license agreement covering the ongoing development of Endiatx’s PillBot. The deal gives Mayo Clinic an equity stake in the robotic stomach camera startup, Endiatx co-founder and CEO Torrey Smith told MassDevice. He... Read More →
Garwood Medical Devices, LLC named as an Awardee in the Innovations for Vets QuickFire Challenge Innovation
BUFFALO, NY – December 16, 2022, Garwood Medical Devices, LLC has been selected as an awardee of the Innovations for Vets Quickfire Challenge launched by Johnson & Johnson Innovation – JLABS with the Johnson & Johnson Office of Military and... Read More →
Anumana and Pfizer Partner to Enable Early Detection of Underdiagnosed Cardiovascular Disease
Companies initiate research agreement supporting development of new AI-ECG algorithm to help identify patients who may be at risk of cardiac amyloidosis CAMBRIDGE, Mass.–(BUSINESS WIRE)–Anumana, Inc., an AI-driven health technology company and portfolio company of nference, has entered into a... Read More →
CardiaCare Announces Licensing and Distribution Agreement to Commercialize its Digital Neuromodulation Wearable for Non-invasive Atrial Fibrillation Treatment
REHOVOT, Israel, Dec. 15, 2022 /PRNewswire/ — CardiaCare, a clinical stage digital therapeutic company developing the world’s first non-invasive, personalized neuromodulation wearable for atrial fibrillation treatment, announced today the execution of a strategic licensing agreement with Dr. Reddy’s Laboratories, a... Read More →